Point-Counterpoint: What Is the Optimal Approach for Detection of Clostridium difficile Infection?
Open Access
- 1 March 2017
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 55 (3) , 670-680
Abstract
INTRODUCTION: In 2010, we published an initial Point-Counterpoint on the laboratory diagnosis of Clostridium difficile infection (CDI). At that time, nucleic acid amplification tests (NAATs) were just becoming commercially available, and the idea of algorithmic approaches to CDI was being explored. Now, there are numerous NAATs in the marketplace, and based on recent proficiency test surveys, they have become the predominant method used for CDI diagnosis in the United States. At the same time, there is a body of literature that suggests that NAATs lack clinical specificity and thus inflate CDI rates. Hospital administrators are taking note of institutional CDI rates because they are publicly reported. They have become an important metric impacting hospital safety ratings and value-based purchasing; hospitals may have millions of dollars of reimbursement at risk. In this Point-Counterpoint using a frequently asked question approach, Ferric Fang of the University of Washington, who has been a consistent advocate for a NAAT-only approach for CDI diagnosis, will discuss the value of a NAAT-only approach, while Christopher Polage of the University of California Davis and Mark Wilcox of Leeds University, Leeds, United Kingdom, each of whom has recently written important articles on the value of toxin detection in the diagnosis, will discuss the impact of toxin detection in CDI diagnosis.Keywords
This publication has 71 references indexed in Scilit:
- Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infectionThe Lancet Infectious Diseases, 2013
- Performance of Clostridium difficile Toxin Enzyme Immunoassay and Nucleic Acid Amplification Tests Stratified by Patient Disease SeverityJournal of Clinical Microbiology, 2013
- Impact of the Type of Diagnostic Assay on Clostridium difficile Infection and Complication Rates in a Mandatory Reporting ProgramClinical Infectious Diseases, 2012
- Real-time polymerase chain reaction testing for Clostridium difficile reduces isolation time and improves patient management in a small community hospitalAmerican Journal of Infection Control, 2012
- Clinical and Laboratory Characteristics of Clostridium difficile Infection in Patients with Discordant Diagnostic Test ResultsJournal of Clinical Microbiology, 2012
- Assessment of Clostridium difficile Infections by Quantitative Detection of tcdB Toxin by Use of a Real-Time Cell Analysis SystemJournal of Clinical Microbiology, 2010
- Impact of Strain Type on Detection of Toxigenic Clostridium difficile: Comparison of Molecular Diagnostic and Enzyme Immunoassay ApproachesJournal of Clinical Microbiology, 2010
- Toxic megacolon associatedClostridium difficilecolitisWorld Journal of Gastrointestinal Endoscopy, 2010
- Evaluation of tcdB Real-Time PCR in a Three-Step Diagnostic Algorithm for Detection of Toxigenic Clostridium difficileJournal of Clinical Microbiology, 2010
- Antibiotic Treatment of Clostridium difficile Carrier Mice Triggers a Supershedder State, Spore-Mediated Transmission, and Severe Disease in Immunocompromised HostsInfection and Immunity, 2009